Evaluation of a new selective chromogenic agar medium for detection of extended-spectrum β-lactamase-producing Enterobacteriaceae

Journal of Clinical Microbiology

Volumn 45, Issue 2, 2007, Pages 501-505

  Glupczynski, Youri ^a   Berhin, Catherine ^a   Bauraing, Caroline ^a   Bogaerts, Pierre ^a  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE;

AGAR MEDIUM; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM COLONY; BACTERIUM DETECTION; BACTERIUM ISOLATION; CITROBACTER FREUNDII; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FALSE POSITIVE RESULT; KLEBSIELLA; KLEBSIELLA OXYTOCA; MORGANELLA MORGANII; NONHUMAN; PRIORITY JOURNAL;

AGAR; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFTAZIDIME; CHROMOGENIC COMPOUNDS; CULTURE MEDIA; ENTEROBACTERIACEAE; FECES; HUMANS; RESPIRATORY SYSTEM; SENSITIVITY AND SPECIFICITY;

CITROBACTER; CITROBACTER FREUNDII; ENTEROBACTER; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA OXYTOCA; MORGANELLA MORGANII;

EID: 33847022997     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02221-06     Document Type: Article

References (30)

1. Ben-Ami, R., M. J. Schwaber S. Navon-Venezia, D. Schwartz, M. Giladi, I. Chmelnitsky, A. Leavitt, and Y. Carmeli. 2006. Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin. Infect. Dis. 42:925-934.
2. Bonnet, R. 2004. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.
3. Bradford, P. A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistant threat. Clin. Microbiol. Rev. 14:933-951.
4. Canton, R., and T. M. Coque. 2006. The CTX-M β-lactamase pandemic. Curr. Opin. Microbiol. 9:1-10.
5. Carricajo, A., A. Treny, N. Fonsale, M. Bes, M. E. Reverdy, Y. Gille, G. Aubert, and A. M. Freydiere. 2001. Performance of the chromogenic medium CHROMagar Staph aureus and the Staphychrom coagulase test in the detection and identification of Staphylococcus aureus in clinical specimens. J. Clin. Microbiol. 39:2581-2583.
6. Ciragil, P., M. Gul, M. Aral, and H. Ekerbicer. 2006. Evaluation of a new chromogenic medium for isolation and identification of common urinary tract pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 25:108-111.
7. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; 15th informational supplement. M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
8. De Gheldre, Y., V. Avesani, C. Berhin, M. Delmée, and Y. Glupczynski. 2003. Evaluation of Oxoid combination discs for detection of extended-spectrum β-lactamases. J. Antimicrob. Chemother. 52:591-597.
9. Diederen, B. M. W., M. L. van Leest, I. van Duijn, P. Willemse, P. H. J. van Keulen, and J. A. J. W. Kluytmans. 2006. Performance of MRSA ID, a new chromogenic medium for detection of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 44:586-588.
10. Gaillot, O., M. Wetsch, N. Fortineau, and P. Berche. 2000. Evaluation of CHROMagar Staph aureus, a new chromogenic medium, for isolation and presumptive identification of Staphylococcus aureus from human clinical specimens. J. Clin. Microbiol. 38:1587-1591.
11. Hengstler, K. A., R. Hammann, and A. M. Fahr. 1997. Evaluation of BBL CHROMagar orientation medium for detection and presumptive identification of urinary tract pathogens. J. Clin. Microbiol. 35:2773-2777.
12. Knothe, H., P. Shah, V. Kremery, M. Antal, and S. Mitsuhashi. 1983. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11:315-317.
13. Livermore, D. M., and P. M. Hawkey. 2005. CTX-M: changing the face of ESBLs in the UK. J. Antimicrob. Chemother. 56:451-454.
14. Loulergue, J., C. de Gialluly, V. Morange, A. Holstein, N. van der Mee-Marquet, and R. Quentin. 2006. Evaluation of a new chromogenic medium for isolation and presumptive identification of methicillin-resistant Staphylococcus aureus from human clinical specimens. Eur. J. Clin. Microbiol. Infect. Dis. 25:407-409.
15. Lucet, J. C., S. Chevret, D. Decre, D. Vanjak, A. Macrez, J. P. Bedos, M. Wolff, and B. Reigner. 1996. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin. Infect. Dis. 22:430-436.
16. Lucet, J. C., D. Decre, D. A. Fichelle, M. L. Joly-Guillou, M. Pernet, C. Deblangy, M. J. Kosmann, and B. Regnier. 1999. Control of a prolonged outbreak of extended-spectrum β-lactamase-producing Enterobacteriaceae in a universiy hospital. Clin. Infect. Dis. 29:1411-1418.
17. Paterson, D. L., W. C. Ko, A. Von Gottberg, J. M. Casellas, L. Mulazimoglu, K. P. Klugman, R. A. Bonomo, L. B. Rice, J. G. McCormack, and V. L. Yu. 2001. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory. J. Clin. Microbiol. 39:2206-2212.
18. Paterson, D. L., W. C. Ko, A. Von Gottberg, S. Mohapatra, J. M. Casellas, H. Goossens, L. Mulazimoglu, G. Trenholme, K. P. Klugman, R. A. Bonomo, L. B. Rice, M. M. Wagener, J. G. McCormack, and V. L. Yu. 2004. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann. Intern. Med. 140:26-32.
19. Paterson, D. L., and R. A. Bonomo. 2005. Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
20. Peña, C., M. Pujol, A. Ricart, C. Ardanuy, J. Ayats, J. Linares, F. Garrigosa, J. Ariza, and F. Gudiol. 1997. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended-spectrum β-lactamase (ESBL-KP) in the intensive care unit. J. Hosp. Infect. 35:9-16.
21. Peña, C., M. Pujol, C. Ardanuy, A. Ricart, R. Pallares, J. Linares, J. Ariza, and F. Gudiol. 1998. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 42:53-58.
22. Pérez-Pérez, F. J., and N. D. Hanson. 2002. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.
23. Perry, J. D., A. Davies, L. A. Butterworth, A. L. J. Hopley, A. Nicholson, and F. K. Gould. 2004. Development and evaluation of a chromogenic agar medium for methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 42:4519-4523.
24. Pfaller, M. A., and J. Segreti. 2006. Overview of the epidemiological profile and laboratory detection of extended-spectrum β-lactamases. Clin. Infect. Dis. 42(Suppl. 4):S153-S163.
25. Philippon, A., G. Ariel, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46:1-11.
26. Ramphal, R., and P. G. Ambrose. 2006. Extended-spectrum β-lactamases and clinical outcomes; current data. Clin. Infect. Dis. 42(Suppl. 4):S164-S172.
27. Soulier, A., F. Barbut, J. M. Ollivier, J. C. Petit, and A. Lienhart. 1995. Decreased transmission of Enterobacteriaceae with extended-spectrum β-lactamases in an intensive care unit by nursing reorganization. J. Hosp. Infect. 31:89-97.
28. Stürenburg, E., and D. Mack. 2003. Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J. Infect. 47:273-295.
29. Troché, G., M.-L. Joly, M. Guibert, and J.-F. Zazzo. 2005. Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey. Infect. Control Hosp. Epidemiol. 26:161-165.
30. Valverde, A., T. M. Coque, M. P. Sanchez-Moreno, A. Rollan, F. Baquero, and R. Canton. 2004. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during non-outbreak situations in Spain. J. Clin. Microbiol. 42:4769-4775.